Bifidobacteria for treating diabetes and related conditions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13377325

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANISCO A/SLANGEBROGADE 1 COPENHAGEN 1001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burcelin, Rémy Escalquens, FR 12 77
Carcano, Didier Paris, FR 23 102
Lahtinen, Sampo Siuntio, FI 33 133

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation